相关实验视频

Updated: Jun 12, 2026

Experimental Human Pneumococcal Carriage

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

一项随机研究,评估五价性脑膜炎球菌疫苗的安全性和免疫性

Yoonjin Kim¹, Sungyeun Bae¹, Kyung-Sang Yu¹

¹Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.

|August 7, 2024

概括

一种新的五价性脑膜炎球菌疫苗 (EuNmCV-5) 在健康成年人中显示出安全性和强烈的免疫性. 与四价疫苗相比,它对血清组A和C的抗体反应更高.

科学领域:

疫苗学疫苗学疫苗学
传染性疾病传染性疾病
临床试验临床试验

背景情况:

脑膜炎球菌疾病仍然是一个重大的公共卫生问题,需要针对各种血清组的疫苗.
目前的疫苗提供对某些血清组的保护,但更广泛的覆盖范围是可取的.

研究的目的:

为了评估EuNmCV-5的安全性,耐受性和免疫性,EuNmCV-5是一种新型五价性脑膜炎球菌疫苗.
为了比较由EuNmCV-5引起的免疫反应与许可的四价性脑膜炎球菌疫苗 (MenACWY-CRM) 相比.

主要方法:

一项随机的,主动控制的,双盲的,首次在60名健康的韩国成年人身上进行的人体第一阶段研究.
参与者接受了一次剂量EuNmCV-5或MenACWY-CRM.
通过不良事件和严重不良事件评估安全性;通过子补剂依赖血清杀菌抗体 (rSBA) 测定测量免疫性.

主要成果:

发现EuNmCV-5在参与者中是安全的,并且耐受良好.
疫苗引起了所有向血清组 (A,C,W,X,Y) 抗体标位的大幅增加.
所有血清组的血清保护率超过96.7%,血清转化率超过85%,与MenACWY-CRM相比,血清组A和C的比率更高.

结论:

EuNmCV-5是一种安全和免疫性五价值脑膜炎球菌疫苗候选剂.
该疫苗显示了针对脑膜炎球菌病的更广泛保护的潜力.
根据这些有前途的第一阶段结果,需要对EuNmCV-5进行进一步的临床开发.

更多相关视频

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

相关概念视频

Bacterial Meningitis

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...

Viral Meningitis

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...

Bacterial Meningitis I: Introduction

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...

Bacterial Meningitis II: Pathophysiology

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...